Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn’s Disease

BACKGROUND: A previously developed clinical decision support tool (CDST) identified patients with Crohn’s disease (CD) most likely to respond to vedolizumab. This study evaluated the ability of the CDST to predict real-world healthcare resource utilization (HRU). METHODS: The Optum and Truven health...

Descripción completa

Detalles Bibliográficos
Autores principales: Dulai, Parambir S, Wan, Yaping, Huang, Zhongwen, Luo, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802432/
https://www.ncbi.nlm.nih.gov/pubmed/36778514
http://dx.doi.org/10.1093/crocol/otac048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802432/
https://www.ncbi.nlm.nih.gov/pubmed/36778514
http://dx.doi.org/10.1093/crocol/otac048

Ejemplares similares